America March 14, 2024
AstraZeneca acquires Amolyt in $1B deal
AstraZeneca, a pharmaceutical giant, announced on Thursday its acquisition of Amolyt Pharma, a clinical stage biotechnology company, in a deal…
America March 14, 2024
AstraZeneca, a pharmaceutical giant, announced on Thursday its acquisition of Amolyt Pharma, a clinical stage biotechnology company, in a deal…
By Rihem Akkouche
America January 8, 2024
In a groundbreaking development, BioMerieux has expanded its initial 16% stake in Lumed, solidifying its grip on the Canadian clinical…
By Rihem Akkouche
America December 19, 2023
In a courtroom drama that unfolded on Tuesday, a Delaware bankruptcy judge, Karen B. Owens, signaled her approval for biotechnology…
By Rihem Akkouche
America November 15, 2023
Silicon Valley cancer diagnostics trailblazer, Guardant Health, is gearing up for an intense legal tussle as it appeals an adverse…
By Rihem Akkouche
America October 30, 2023
In a stunning financial maneuver, Abrdn, the renowned investment powerhouse, has unleashed a dazzling financial onslaught by acquiring the health…
By Rihem Akkouche
America October 20, 2023
In a thrilling turn of events, the Paris-based biotechnology firm Abivax SA defied market perplexity as it successfully raised $236…
By Rihem Akkouche